Human Amniotic Epithelial Cells Exert Anti-Cancer Effects Through Secretion of Immunomodulatory Small Extracellular Vesicles (Sev) Publisher



Bolouri MR^{1, 6} ; Ghods R^{2, 3} ; Zarnani K⁴ ; Vafaei S⁵ ; Falak R^{1, 6} ; Zarnani AH^{4, 5, 6} Show Affiliations
Source: Cancer Cell International Published:2022

Abstract

We identified here mechanism by which hAECs exert their anti-cancer effects. We showed that vaccination with live hAEC conferred effective protection against murine colon cancer and melanoma but not against breast cancer in an orthotopic cancer cell inoculation model. hAEC induced strong cross-reactive antibody response to CT26 cells, but not against B16F10 and 4T1 cells. Neither heterotopic injection of tumor cells in AEC-vaccinated mice nor vaccination with hAEC lysate conferred protection against melanoma or colon cancer. Nano-sized AEC-derived small-extracellular vesicles (sEV) (AD-sEV) induced apoptosis in CT26 cells and inhibited their proliferation. Co-administration of AD-sEV with tumor cells substantially inhibited tumor development and increased CTL responses in vaccinated mice. AD-sEV triggered the Warburg’s effect leading to Arginine consumption and cancer cell apoptosis. Our results clearly showed that it is AD-sEV but not the cross-reactive immune responses against tumor cells that mediate inhibitory effects of hAEC on cancer development. Our results highlight the potential anti-cancer effects of extracellular vesicles derived from hAEC. © 2022, The Author(s).